The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Replimune
Consulting or Advisory Role - Taiho Pharmaceutical
An open-label clinical trial of RP2 and RP3 oncolytic immunotherapy in combination with atezolizumab plus bevacizumab for the treatment of patients with advanced colorectal carcinoma.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Fulgent Genetics; G1 THerapeutics; Isofol Medical; Jazz Pharmaceuticals; Merck Serono; Oncocyte; Roche
Consulting or Advisory Role - 3T BioSciences; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Ashwin Somasundaram
No Relationships to Disclose
 
Michael Sangmin Lee
Consulting or Advisory Role - Bayer Health; Delcath Systems; G1 Therapeutics; Imvax; Pfizer
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); EpimAb BioTherapeutics (Inst); Erasca, Inc (Inst); Merck (Inst); Repare Therapeutics (Inst); TriSalus Life Sciences (Inst); Xilis (Inst)
 
Davendra Sohal
Consulting or Advisory Role - AADi; AstraZeneca; Cancer Commons; Elevar Therapeutics; Totus Medicines; TransThera Biosciences; Valar Labs
Speakers' Bureau - Genentech; Incyte; Seagen
Research Funding - AADi (Inst); Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Pharmaceutical (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Pancreatic Cancer Action Network (Inst); Regeneron (Inst); Roche (Inst)
 
Rachael A Safyan
Honoraria - Curio Science; Guardant Health
Research Funding - Merck (Inst)
 
Mojun Zhu
No Relationships to Disclose
 
Jeremy Clifton Jones
No Relationships to Disclose
 
Aditya Bhansali
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Roza Kalwar
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
May Cho
No Relationships to Disclose
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier; IMEDEX
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche; Lilly (Inst); OBI Pharma
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)